Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EMR vs MRNA✓SelectedUSD · MRNAEMR vs MRNA performance historyLatest closeAs of-2.72%11/19
Stock and ETF performance explorer

EMR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+199.4%
MRNA return
+806.0%
Excess return
-606.6%
Maximum drawdown
-50.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.7%+1.3%-4.0%-2.8%
7D-5.2%-13.8%+8.6%-4.8%
30D-1.4%-17.7%+16.2%-0.9%
3M+0.4%+14.3%-14.0%-0.4%
6M+21.5%+336.0%-314.5%+11.4%
YTD+20.5%+575.9%-555.4%+7.8%
1Y+24.8%+724.4%-699.6%+10.4%
3Y+85.7%+160.8%-75.1%+69.4%
5Y+86.1%-24.4%+110.5%+71.9%
All+199.4%+806.0%-606.6%+162.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling